20.5 C
New York
Wednesday, June 3, 2026

Tag: editing

ZHITAI at COMPUTEX: Targeting Gamers and High-Performance Creators with Flagship SSD Launches Across the APAC Region

TAIPEI, June 2, 2026 /PRNewswire/ -- As the global SSD market welcomes a new era of diverse choices, ZHITAI, the consumer memory brand under YMTC,...

CelHive: The Rising Unicorn Transforming the Future of AI Workforces

Revolutionary AI platform achieves 200,000 users milestone, showcasing unprecedented growth in the booming AI agent technology sector
Revolutionary AI platform achieves 200,000 users milestone, showcasing unprecedented growth in the booming AI agent technology sector

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with Janus Henderson Investors, a global asset management firm, for the purchase and sale of 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License...

Boehringer Ingelheim Celebrates Next Generation of Biomedical Researchers at 2025 Veterinary Scholars Symposium

Student researchers from Mississippi State University and The Ohio State University received Boehringer Ingelheim research awards DULUTH, Ga., Aug. 11, 2025 /PRNewswire/ -- Veterinary research took...

mRNA Synthesis Raw Materials Strategic Market Analysis Report 2025 | Market to Reach $2 Billion by 2030 – Rising Collaboration Between mRNA Developers and...

Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory compliance, and supply chain resilience. Emerging applications in personalized medicine and gene editing further boost this market.
Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory compliance, and supply chain resilience. Emerging applications in personalized medicine and gene editing further boost this market.

The Los Angeles Film School Celebrates its Nominated Alumni Ahead of the 77th EMMY Awards

L.A. Film School graduates contribute across 22 nominated projects, with two earning individual honors in top categories, reinforcing the college's entertainment industry impact. LOS ANGELES,...

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with Janus Henderson Investors, a global asset management firm, to purchase 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant in a registered direct offering. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

Instructure Introduces an Improved Educational YouTube Experience Through Canvas Studio, Reinforcing Commitment to Student Data Privacy

The new YouTube Player for Education focuses students on learning by showing videosdistraction-free SALT LAKE CITY, Aug. 8, 2025 /PRNewswire/ -- Instructure, the world's leading edtech...

Big Jump Leverages AI-Driven Content Strategy to Boost Organic Traffic and Brand Visibility for PONS.ai, F45 Kwun Tong, and Hang Po Transportation

Hong Kong, Aug. 7, 2025 /PRNewswire/ -- Hong Kong-based digital transformation consultancy Big Jump Digital announced today that its AI marketing platform has successfully delivered...

SIGGRAPH 2025 Ignites Global AI Dialogue Across Art, Science, and Industry

Conference Unites Diverse Disciplines to Explore the Expanding Role of Artificial Intelligence in Creativity, Computation, and Connection. VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ -- From...

Introducing VIOFO A329S 3CH with 2K Infrared Fisheye Cabin Camera — Capture Both Inside & Out with Enhanced Clarity

SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- Following the great response to VIOFO A329, VIOFO launched the A329S 3CH in response to the requests for...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEditing